Objective: Bluetongue virus is an arthropod-borne Orbivirus in the family Reoviridae which infects both domestic and wild ruminants. Bluetongue disease is a List A disease of the Office of International Epizootics. To the best of our knowledge, no report has been published on bluetongue disease of sheep flocks of Southeast of Iran. The objective of this study was to describe the seroprevalence rates of BTV in sheep flocks in southeast of Iran. Methods: The blood samples were collected randomly from herds of Southeast of Iran. A total of 188 sera samples (94 male, 94 female) collected between 2009 and 2010, were available. Antibodies to BTV in sera were detected by using a commercial competitive ELISA (Institute Pourquier, Montpellier, France) according to manufacturer’s instructions. Results: The seroprevalence rates were 6.57 %for sheep herds. Within a herd, prevalence of BTV seropositive animals ranged from 0% to 42.85%. 33.3% sheep flocks were positive to BTV antibodies. Sex didn't affect the rate of seropositivity, but the rate of seropositivity was significantly changed in different age groups. Conclusion: This study describes the seroprevalence rates of Bluetongue virus (BTV) in sheep flocks in southeast of Iran for the first time.

Objective: To describe the seroprevalence rate of bluetongue virus (BTV) in goat flocks in southeast of Iran.Methods:93 sera samples were collected between 2011 and 2012. Antibodies to BTV in sera were detected by using a commercial competitive ELISA 3 according to manufacturer’s instructions. The blood samples were collected randomly from herds of southeast of Iran. A total of Results: The seroprevalence rates were 67.7% for goats. Within a herd, prevalence of BTV seropositive animals ranged from 33.3% to 100.0%. All goat flocks were positive to BTV antibodies.Conclusions:This study describes a high seroprevalence rate of BTV in goat flocks in southeast of Iran for the first time.

A five-year-old cow was referred to the veterinary faculty hospital for treatment of a swelling mass with a cutaneous fistula at the left lower part of th e chest wall, between 7th till 9th intercostals space. Abdominal pain in palpation of the mass was observed with no abnormality in clinical symptoms. In surgical exploration, skin in cision was carried out on the swelling mass and surprisingly a sinus tract with a sharp metallic rod (26 cm length) that continued to the reticulum lumen was identified. Because of unsuccessful attempting to remove of the foreign body, flank laparotomy and rumenotomy was performed. After one month, the cow led to complete recovery.

A five-year-old cow was referred to the veterinary faculty hospital for treatment of a swelling mass with a cutaneous fistula at the left lower part of the chest wall, between 7th till 9th intercostals space. Abdominal pain in palpation of the mass was observed with no abnormality in clinical symptoms. In surgical exploration, skin incision was carried out on the swelling mass and surprisingly a sinus tract with a sharp metallic rod (26 cm length) that continued to the reticulum lumen was identified. Because of unsuccessful attempting to remove of the foreign body, flank laparotomy and rumenotomy was performed. After one month, the cow led to complete recovery.

OBJECTIVETo describe the seroprevalence rate of bluetongue virus (BTV) in goat flocks in southeast of Iran.

METHODSThe blood samples were collected randomly from herds of southeast of Iran. A total of 93 sera samples were collected between 2011 and 2012. Antibodies to BTV in sera were detected by using a commercial competitive ELISA 3 according to manufacturer's instructions.

RESULTSThe seroprevalence rates were 67.7% for goats. Within a herd, prevalence of BTV seropositive animals ranged from 33.3% to 100.0%. All goat flocks were positive to BTV antibodies.

CONCLUSIONSThis study describes a high seroprevalence rate of BTV in goat flocks in southeast of Iran for the first time.

OBJECTIVESTo elucidate the possible ways by which hydroxyurea molecules affect globin chain (α or β-like) synthesis.

METHODSA total of 23 thalassemia intermedia patients (13 male and 10 female) aged between 5 and 26 years were treated for five months with 15 mg/(kg·day) of hydroxyurea. Hemoglobins electrophoresis and globin chain electrophoresis was performed on each sample at different time points before and during the treatment.

RESULTSFetal hemoglobin increased significantly in most patients and average episodes of transfusion decreased. Both Gγ and Aγ-globin chains increased significantly and α-globin:Nonα-globin chain as well as Gγ-globin:Aγ globin chains ratios decreased.

CONCLUSIONSImprovement in α:non-α ratio and consequent decrease of free α-globin chain might be the cause of beneficial effects of hydroxyurea therapy. Two patients who felt better didn't show significant increase in their fetal hemoglobin level, and this is in contradiction with the hypothesis claiming that the HbF level increase is the cause of such therapeutic effect. In spite of the unclear mechanism of action of this drug, hydroxyurea therapy had noticeable impacts on thalassemia intermedia and also sickle cell disease and even patients suffering from thalassemia major.